Gail Roboz
盖尔·罗博兹
MD
Professor of Medicine; Director, Leukemia Program医学教授；白血病项目主任
👥Biography 个人简介
Director of the Leukemia Program at Weill Cornell Medicine, recognized for leadership in AML and MDS clinical trials and patient-centered care advocacy. A prominent voice in advancing novel agents and improving quality of life for leukemia patients.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
AML Clinical Trial Leadership
Led and co-led numerous pivotal AML trials introducing novel therapeutics including glasdegib, CPX-351, and immunotherapy combinations, expanding treatment options for diverse patient populations.
Patient-Centered AML Care
Championed integration of patient-reported outcomes and supportive care measures into AML trial design, elevating the standard for holistic leukemia treatment evaluation.
Representative Works 代表性著作
Glasdegib in combination with cytarabine and daunorubicin in AML
Leukemia (2020)
Evaluated Hedgehog pathway inhibition combined with intensive chemotherapy, adding to the growing armamentarium of targeted agents in frontline AML treatment.
Treatment of AML in older patients
Blood (2019)
Landmark review summarizing evidence-based strategies for managing AML in elderly patients, widely cited in guidelines for frailty-adapted therapy decisions.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Elihu Estey
Fred Hutchinson Cancer Center
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Naval Daver
The University of Texas MD Anderson Cancer Center
Courtney DiNardo
The University of Texas MD Anderson Cancer Center
关注 盖尔·罗博兹 的研究动态
Follow Gail Roboz's research updates
留下邮箱，当我们发布与 Gail Roboz（Weill Cornell Medicine / NewYork-Presbyterian Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment